Sickle Cell Treatment Gap: Only 3% of US Patients Receive Red Blood Cell Exchange
Fewer than 3% of US sickle cell disease patients receive red blood cell exchange therapy, according to new research. Despite 91% of surveyed healthcare providers reporting institutional access to the ... Read More